OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI ...
Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...
OpenAI CEO Sam Altman will brief U.S. officials on super-agents—AI systems set to revolutionize software development, finance ...
Retro Biosciences Inc., a startup using artificial intelligence to discover new drugs, is reportedly raising $1 billion in ...
"And of course it's smarter than us. Of course, it can do things we can't, but also who really cares? I think it's only weird ...
President Donald Trump talked up a joint venture investing up to $500 billion for infrastructure tied to AI by a new ...
The $500 billion Stargate Initiative — led by Trump, OpenAI, SoftBank, and Oracle — is set to revolutionize U.S. AI ...